Brief: Lipidor And Cannassure Enter Exclusive Licensing Agreement

Lipidor AB

18/01/2021 07:18

Jan 18 (Reuters) - Lipidor AB  LIPI.ST :
    * LIPIDOR AND CANNASSURE ENTER EXCLUSIVE LICENSING AGREEMENT
REGARDING TOPICAL MEDICAL CANNABIS PRODUCTS BASED ON LIPIDOR'S
AKVANO ®  TECHNOLOGY
    * RECEIVES A ROYALTY OF 15-17.5% ON FUTURE PRODUCT SALES
    * WILL RECEIVE AN ADDITIONAL MILESTONE PAYMENT IN FORM OF 1%
OF
SHARE CAPITAL VALUE OF CANNASSURE, UP TO A MAXIMUM OF EUR
350,000
    * UNDER DEAL, CANNASSURE HAS EXCLUSIVE RIGHT TO USE
LIPIDOR'S
PROPRIETARY DRUG DELIVERY TECHNOLOGY AKVANO(®) IN MEDICINAL
CANNABIS PRODUCTS

Source text for Eikon:  ID:nWkr9L59ny 
Further company coverage:  LIPI.ST 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))